Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases.
Deitcher
Steven R
SR
The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. deitchs@ccf.org
Ngengwe
Raphael
R
Kaplan
Robert
R
Liebman
Howard
H
Kaplan
Karen
K
Blinder
Morey
M
D000230:Adenocarcinoma / Q000150:complications / Q000556:secondary; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000150:complications; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000150:complications; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000097:blood / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011169:Portal Vein; D011655:Pulmonary Embolism / Q000188:drug therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D014682:Vena Cava, Inferior; D020246:Venous Thrombosis / Q000188:drug therapy; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006629:Hirudins; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D014859:Warfarin; D006493:Heparin; C083544:lepirudin